I have a special interest in Alzheimer’s disease. For nearly 25 years, I practiced general neurology in Portland, Oregon, and ...

Scientists are exploring using earpiece microphones, also known as hearables, to detect and 'listen' to early signs of ...

New research from Wake Forest University School of Medicine suggests that living in a disadvantaged neighborhood is ...

Neuroscientist Gary Gibson, Ph.D. '73, keeps a framed picture of a cell derived from the skin cells of a person with ...

The daily medication, called hydromethylthionine mesylate (HMTM), was developed by British firm TauRX in Aberdeen ...

Nearly 80% of caregiving for people with Alzheimer’s disease or dementia occurs in the home but most caregivers don’t realize ...

We have entered a new era of improved and emerging biologically-based diagnostic biomarkers for Alzheimer's disease (AD) and ...

A ‘GAME-changing’ drug which could slow down Alzheimer’s disease is being considered for potential use on the NHS. The daily medication, called hydromethylthionine mesylate ...

Uncover the challenges of ensuring road safety for senior drivers with mild cognitive impairment. Learn why our healthcare system needs better monitoring and testing.

In an ongoing effort to help public health leaders serving American Indian and Alaska Native communities address brain health ...

Globally, approximately 139 million people are expected to have Alzheimer's disease (AD) by 2050. Magnetic resonance imaging ...